UNSPSC 51144301: Phendimetrazine

This classification denotes a cns stimulant and anorexiant with the molecular formula C12H17NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) AB2794W8KV, chemically known as 3,4-dimethyl-2-phenylmorpholine but more generally known as phendimetrazine, which bears US NIH Compound Identifier 12460. European Medicines Agency schedules Phendimetrazine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09756MIG. The term PHENDIMETRAZINE is an International Non-Proprietary Name.

UNSPSC 51144301 Phendimetrazine is a Commodity code that in practice captures pharmaceutical procurement across state and local health agencies, though recent activity shows substantial divergence from the code's nominal scope. State and local governments soliciting under this code are acquiring naloxone kits, over-the-counter products, and generic multi-source pharmaceuticals through cooperative purchasing agreements and competitive bidding processes. The issuing bodies include county health departments (Seminole County, Florida), state health and human services commissions (Texas HHS Commission), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance, serving state and local government facilities across multiple jurisdictions including Oregon). Scope of work spans emergency response medications (naloxone and drug deactivation systems for community health initiatives), direct-to-manufacturer prescription fulfillment programs designed to bypass traditional pharmacy benefit managers and wholesalers, and bulk pharmaceutical supply contracts with specific National Drug Code requirements and cGMP and Drug Supply Chain Security Act certification mandates.

Activity concentrates in Florida, Texas, and Minnesota, with the multistate cooperative vehicle extending procurement reach across participating jurisdictions. Seminole County, Florida released IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries and a response deadline of July 26, 2023. The Texas HHS Commission issued RFI HHS0017013 on April 3, 2026, to gather vendor capability information on direct-to-manufacturer prescription programs without formal competitive structure or timeline. The Minnesota Department of Administration's Office of State Procurement, administering MMCAP, released RFP S1070000015802 on January 20, 2026, for generic multi-source pharmaceuticals and OTC products through three authorized wholesalers with pricing weighted at 75 percent and a proposal deadline of March 26, 2026; awards effective July 1, 2026. The code shows limited activity specifically aligned with phendimetrazine; the tagged opportunities reflect broader pharmaceutical supply and community health procurement that state and local agencies route through this and related pharmaceutical codes.